Traws Pharma (TRAW) Stock: Buy, Sell, or Hold?
$0.25
+0.02 (+11.11%)
▲
5d:
-6.92%
30d:
-39.04%
90d:
-58.33%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (88%)
Quality Score
53/100
Position
OVERSOLD
30-Day Fair Range
$0.27 – $0.44
Position: OVERSOLD
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$1.00
+300.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.22 / $0.37
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: TRAW shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When TRAW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TRAW is currently trading at $0.25, which is considered oversold relative to its 30-day fair value range of $0.27 to $0.44.
Technical Outlook: Technically, TRAW is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.37. The stock is showing strong short-term momentum, up 11.1% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+300.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TRAW is in a strong downtrend. Immediate support is located at $0.22, while resistance sits at $0.37. The stock is showing strong short-term momentum, up 11.1% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $1.00 (+300.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.27 -
$0.44
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Trading Range & Key Levels
30-Day Trading Range
$0.27 -
$0.44
Current vs Trading Range
OVERSOLD
Support Level
$0.22
Resistance Level
$0.37
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.1%)
- BULLISH: Trading 300.0% below Wall St target ($1.00)
- WARNING: Composite score 53/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.13
Wall Street Target
$1.00
(+300.0%)
Revenue Growth (YoY)
-100.0%
Share TRAW Analysis
Share this live TRAW analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TRAW)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express optimistic views on $TRAW, expecting warrant exercise and potential re-rating.
Key Retail Themes:
Anticipated warrant exercise
Expected re-rating
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:08 PM ET
Data refreshes hourly during market hours. Next update: 10:08 PM
Data refreshes hourly during market hours. Next update: 10:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRAW showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TRAW Research Pages